Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5921589, 6 pages
http://dx.doi.org/10.1155/2016/5921589
Research Article

Serum Sialic Acid Level Is Significantly Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: A Cross-Sectional Study

1Department of Internal Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China
2Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China
3Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China

Received 1 October 2015; Revised 21 November 2015; Accepted 8 December 2015

Academic Editor: Xue Shi

Copyright © 2016 Zhenya Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. D. Williams, J. Stengel, M. I. Asike et al., “Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study,” Gastroenterology, vol. 140, no. 1, pp. 124–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-G. Fan and G. C. Farrell, “Epidemiology of non-alcoholic fatty liver disease in China,” Journal of Hepatology, vol. 50, no. 1, pp. 204–210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. G. C. Farrell and C. Z. Larter, “Nonalcoholic fatty liver disease: from steatosis to cirrhosis,” Hepatology, vol. 43, no. 2, pp. S99–S112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Adams, J. F. Lymp, J. S. Sauver et al., “The natural history of nonalcoholic fatty liver disease: a population-based cohort study,” Gastroenterology, vol. 129, no. 1, pp. 113–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Chalasani, Z. Younossi, J. E. Lavine et al., “The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association,” Hepatology, vol. 55, no. 6, pp. 2005–2023, 2012. View at Publisher · View at Google Scholar
  6. E. Fabbrini, S. Sullivan, and S. Klein, “Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications,” Hepatology, vol. 51, no. 2, pp. 679–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hamaguchi, T. Kojima, N. Takeda et al., “The metabolic syndrome as a predictor of nonalcoholic fatty liver disease,” Annals of Internal Medicine, vol. 143, no. 10, pp. 722–728, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Xu, C. Yu, H. Ma, L. Xu, M. Miao, and Y. Li, “Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai study,” American Journal of Gastroenterology, vol. 108, no. 8, pp. 1299–1304, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. H. J. Kim, H. J. Kim, K. E. Lee et al., “Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults,” Archives of Internal Medicine, vol. 164, no. 19, pp. 2169–2175, 2004. View at Publisher · View at Google Scholar
  10. T. Angata and A. Varki, “Chemical diversity in the sialic acids and related α-keto acids: an evolutionary perspective,” Chemical Reviews, vol. 102, no. 2, pp. 439–470, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Varki, “Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins,” Nature, vol. 446, no. 7139, pp. 1023–1029, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. J. Waters, E. Lewry, and C. A. Pennock, “Measurement of sialic acid in serum and urine: clinical applications and limitations,” Annals of Clinical Biochemistry, vol. 29, no. 6, pp. 625–637, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Rajappa, S. Ikkruthi, H. Nandeesha et al., “Relationship of raised serum total and protein bound sialic acid levels with hyperinsulinemia and indices of insulin sensitivity and insulin resistance in non-diabetic normotensive obese subjects,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 7, no. 1, pp. 17–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. F. H. Yerlikaya, A. Toker, H. Çiçekler, and A. Arbaş, “The association of total sialic acid and malondialdehyde levels with metabolic and anthropometric variables in obesity,” Biotechnic and Histochemistry, vol. 90, no. 1, pp. 31–37, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. L. M. Browning, S. A. Jebb, G. D. Mishra et al., “Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women,” International Journal of Obesity, vol. 28, no. 8, pp. 1004–1010, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Xu, X. Wan, L. Xu et al., “Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds,” Journal of Hepatology, vol. 62, no. 6, pp. 1412–1419, 2015. View at Publisher · View at Google Scholar
  17. P. Xu, C.-F. Xu, X.-Y. Wan et al., “Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study,” World Journal of Gastroenterology, vol. 20, no. 33, pp. 11865–11870, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. G. Fan, J. D. Jia, Y. M. Li et al., “Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010,” Journal of Digestive Diseases, vol. 12, pp. 38–44, 2011. View at Google Scholar
  19. H. Yki-Järvinen, “Liver fat in the pathogenesis of insulin resistance and type 2 diabetes,” Digestive Diseases, vol. 28, no. 1, pp. 203–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Rajappa, S. Ikkruthi, H. Nandeesha et al., “Relationship of raised serum total and protein bound sialic acid levels with hyperinsulinemia and indices of insulin sensitivity and insulin resistance in non-diabetic normotensive obese subjects,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 7, no. 1, pp. 17–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. D. Flynn, R. J. M. Corrall, P. J. Waters, and C. A. Pennock, “Sialic acid and cardiovascular mortality,” The British Medical Journal, vol. 302, article 533, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Crook, P. Lumb, V. Andrews, and R. Swaminathan, “Serum total sialic acid, a reputed cardiovascular risk factor, and its relationship to lipids, plasma fasting insulin, blood pressure and body mass index in normal individuals,” Clinical Science, vol. 95, no. 1, pp. 53–57, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. D. E. McMillan, “Increased levels of acute-phase serum proteins in diabetes,” Metabolism, vol. 38, no. 11, pp. 1042–1046, 1989. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Wieckowska, A. J. McCullough, and A. E. Feldstein, “Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future,” Hepatology, vol. 46, no. 2, pp. 582–589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Eguchi, Y. Ikeda, T. Ookawara et al., “Modification of oligosaccharides by reactive oxygen species decreases sialyl lewis x-mediated cell adhesion,” Glycobiology, vol. 15, no. 11, pp. 1094–1101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Rajasekar, K. Balasaraswathi, and C. V. Anuradha, “Effects of L-carnitine on RBC membrane composition and function in hyperinsulinemic rats,” Italian Journal of Biochemistry, vol. 56, no. 1, pp. 53–60, 2007. View at Google Scholar · View at Scopus
  27. R. Iijima, H. Takahashi, R. Namme, S. Ikegami, and M. Yamazaki, “Novel biological function of sialic acid (N-acetylneuraminic acid) as a hydrogen peroxide scavenger,” FEBS Letters, vol. 561, no. 1–3, pp. 163–166, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. A. C. P. Volp, F. C. S. Silva, and J. Bressan, “Hepatic inflammatory biomarkers and its link with obesity and chronic diseases,” Nutrición Hospitalaria, vol. 31, no. 5, pp. 1947–1956, 2015. View at Publisher · View at Google Scholar
  29. L. Chrostek, L. Supronowicz, A. Panasiuk, B. Cylwik, E. Gruszewska, and M. Szmitkowski, “Serum sialic acids levels according to the severity of liver cirrhosis,” Journal of Clinical Laboratory Analysis, vol. 28, pp. 465–468, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Crook, J. C. Pickup, P. J. Lumb, F. Georgino, D. J. Webb, and J. H. Fuller, “Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB complications study,” Diabetes Care, vol. 24, no. 2, pp. 316–322, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Targher and G. Arcaro, “Non-alcoholic fatty liver disease and increased risk of cardiovascular disease,” Atherosclerosis, vol. 191, no. 2, pp. 235–240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Targher, F. Marra, and G. Marchesini, “Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?” Diabetologia, vol. 51, no. 11, pp. 1947–1953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Angulo, “Nonalcoholic fatty liver disease,” The New England Journal of Medicine, vol. 346, no. 16, pp. 1221–1231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. D. H. Sinn, G.-Y. Gwak, H. N. Park et al., “Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults,” The American Journal of Gastroenterology, vol. 107, no. 4, pp. 561–567, 2012. View at Publisher · View at Google Scholar · View at Scopus